We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Are New “Quality of Life Drugs” Worth the Expense?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > News > Are New “Quality of Life Drugs” Worth the Expense?
NewsSpecialties

Are New “Quality of Life Drugs” Worth the Expense?

Andrew Schorr
Andrew Schorr
Share
4 Min Read
SHARE

Very recently a review committee in the U.K. made a preliminary recommendation that the government’s National Health Service should not pay for a newly approved medicine that greatly reduces or alleviates the symptoms of myelofibrosis (MF). MF develops when there is progressive scarring in the bone marrow that affects one’s ability to make blood cells. Other organs like the spleen and liver try to take over the job and they become enlarged. Along with that, a patient experiences itching, fatigue and weight loss, as well as general malaise and suffering.

Very recently a review committee in the U.K. made a preliminary recommendation that the government’s National Health Service should not pay for a newly approved medicine that greatly reduces or alleviates the symptoms of myelofibrosis (MF). MF develops when there is progressive scarring in the bone marrow that affects one’s ability to make blood cells. Other organs like the spleen and liver try to take over the job and they become enlarged. Along with that, a patient experiences itching, fatigue and weight loss, as well as general malaise and suffering. While a new oral medicine, Jakafi in the U.S. and Jakavi in Europe, has not been proven to reduce or reverse the scarring (fibrosis), most patients feel the drug gives them back a full and productive life. However, it’s very expensive, more than $7,000 a month.

I know all about this personally, since I was officially diagnosed with MF nine months ago and began taking the medicine as symptoms developed last fall. It has worked wonders. I thank my lucky stars that my U.S. private insurance pays for it. It allows me to be productive, support my family and contribute to others. My belief is that the expenditure is worth it not only for me, but for society. By helping me feel good I can work, pay taxes and support others.

The UK panel faces tough choices. Money spent on a “quality of life” drug has to come from somewhere in the health system. I understand that. I also understand these drugs are priced very high to bring a return on investment to the pharmaceutical company, often initially a smaller one that took the risk to develop an important new medicine. In this case, the pre-existing treatments are not very effective.

More Read

whiplash pain relief tips
Alternative Medicine Practices For Combatting Symptoms Of Menopause
SaaS Firm Crowdfunds “People-Focused” Image Sharing
A Heart to Heart about the Effects of Exercise on Cardiovascular Health
101-Year-Old Paraglider
7 Healthcare Advancements For Penile Health

It would be great if this new drug can be shown in the long run to treat and reverse the underlying disease or significantly lengthen survival. So far there is no evidence for that. Fortunately, other drugs, perhaps used in combination, may lead to that result. But, in the meantime, should the UK, and possibly other government health systems, force patients to suffer when breakthrough medicines exist?

Fortunately, the decision is not final yet and there is a period of comment until June. My hope is the pharmaceutical company, advocates, patients, and the government can all reach a middle ground. Knowing how this “quality of life” drug has allowed me to live a full life, I would hate it if that opportunity is denied to my brothers and sisters in the U.K. or anywhere else.

What are your views on the tough choices for paying for such treatments in these tight economic times?

Wishing you the best of health!

Andrew

TAGGED:cancerpharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026
Flat editorial illustration: Healthcare ethics-and-law training, shown through a coached clinical role-play where structured disc
Medical Ethics and the Law: The Training Behind Professionals Who Resolve Healthcare Disputes
Uncategorized
November 6, 2026

You Might also Like

pregnant woman waking up early
PregnancySpecialties

5 Habits to Get into Early When You’re Pregnant

February 18, 2022
Image
Public Health

What To Do About Heroin and Oxycontin

April 26, 2013

Recognition for NYC Nurses: Video

November 2, 2012
psychiatric drug development
BusinessFinanceSpecialties

Few Psych Meds Coming Our Way

June 18, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?